Drreddys Laboratories | RDY - Equity Capital And Reserves


Drreddys Laboratories reported INR380.46B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
ANI Pharmaceuticals USD 597.21M 34.91M Jun/2026
Aurora Cannabis CAD 511.83M 24.53M Mar/2026
Bayer EUR 29.71B 863M Jun/2026
Canopy Growth CAD 697.59M 60.58M Mar/2026
Cipla INR 344.32B 15.13B Mar/2026
Corcept Therapeutics USD 705.78M 67.79M Jun/2026
Drreddys Laboratories INR 380.46B 376.31B Mar/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Lonza CHF 9.13B 513M Dec/2025
Novartis USD 41.95B 3.02B Jun/2026
Pacira USD 671.98M 18.08M Jun/2026
Phibro Animal Health USD 385.48M 23.65M Jun/2026
Prestige Brands USD 1.92B 29.2M Jun/2026
Richter Gedeon HUF 1.46T 59.22B Mar/2026
Sun Pharmaceuticals INR 835.7B 57.5B Mar/2026
Supernus Pharmaceuticals USD 1.03B 45.58M Jun/2026
Teva Pharmaceutical Industries USD 7.75B 475M Jun/2026